The invention provides application of
urolithin A in Alzheimer's
disease, belongs to the technical field of
medicinal chemistry and treatment of mental diseases, and aims to solve the problem of
social anxiety caused by the Alzheimer's
disease. According to the application disclosed by the invention, the mitochondrial
autophagy effect of
urolithin A is utilized, A beta is eliminated, a key
brain region loop aBLA-vCA1 is repaired, and the
anxiety symptom of a patient suffering from the Alzheimer's
disease is relieved. According to the present invention, with the application of the
urolithin A in the treatment of Alzheimer's disease, through the mitochondrial
autophagy function of the urolithin A, the targeted removal of A beta and the repair of the damaged basal outer side amygdala
nucleus and
hippocampus loop are achieved so as to effectively relieve the
anxiety symptom of the patient and provide the new strategy for the AD treatment.